VSA001

· Visirna Therapeutics HK Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VSA001, covering 2026-02-27 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3 Study of ARO-APOC3 / VSA001 / SAR449124 (Plozasiran) in Chinese Adults With Familial Chylomicronemia Syndrome [Phase 3]

See pricing